Literature DB >> 18281897

Reliability of P50 auditory sensory gating measures in infants during active sleep.

Sharon K Hunter1, Nereida Corral, Heather Ponicsan, Randal G Ross.   

Abstract

This study assessed reliability of auditory sensory gating in young infants from 1-4 months of age using a paired-click paradigm in which auditory 'clicks' were presented at an interstimulus interval of 500 ms. Evoked potential component P1 was measured during periods of active sleep on two different occasions. Amplitudes, latencies, and ratio of the evoked potentials to each of the auditory clicks were compared. Significant reliability was found in the response ratio, response latency to the first stimulus, and response amplitude to the second stimulus, with a trend toward significance for response latency to the second stimulus and response amplitude to the first stimulus. The results suggest that auditory sensory gating can be reliably measured during active sleep in young infants and might be a useful tool in the study of neurodevelopmental disorders.

Entities:  

Mesh:

Year:  2008        PMID: 18281897     DOI: 10.1097/WNR.0b013e3282f35823

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  17 in total

1.  Interaction of maternal choline levels and prenatal Marijuana's effects on the offspring.

Authors:  M Camille Hoffman; Sharon K Hunter; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman
Journal:  Psychol Med       Date:  2019-07-31       Impact factor: 7.723

Review 2.  Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation.

Authors:  Randal G Ross; Robert Freedman
Journal:  Schizophr Bull       Date:  2015-05-04       Impact factor: 9.306

3.  Oscillatory dynamics and functional connectivity during gating of primary somatosensory responses.

Authors:  Alex I Wiesman; Elizabeth Heinrichs-Graham; Nathan M Coolidge; James E Gehringer; Max J Kurz; Tony W Wilson
Journal:  J Physiol       Date:  2016-12-12       Impact factor: 5.182

Review 4.  The human CHRNA7 and CHRFAM7A genes: A review of the genetics, regulation, and function.

Authors:  Melissa L Sinkus; Sharon Graw; Robert Freedman; Randal G Ross; Henry A Lester; Sherry Leonard
Journal:  Neuropharmacology       Date:  2015-02-19       Impact factor: 5.250

5.  Stability of P50 auditory sensory gating during sleep from infancy to 4 years of age.

Authors:  Sharon K Hunter; Sabreena J Gillow; Randal G Ross
Journal:  Brain Cogn       Date:  2015-01-14       Impact factor: 2.310

6.  Diminished cerebral inhibition in neonates associated with risk factors for schizophrenia: parental psychosis, maternal depression, and nicotine use.

Authors:  Sharon K Hunter; Michael A Kisley; Lizbeth McCarthy; Robert Freedman; Randal G Ross
Journal:  Schizophr Bull       Date:  2010-04-19       Impact factor: 9.306

7.  Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk.

Authors:  Randal G Ross; Sharon K Hunter; Lizbeth McCarthy; Julie Beuler; Amanda K Hutchison; Brandie D Wagner; Sherry Leonard; Karen E Stevens; Robert Freedman
Journal:  Am J Psychiatry       Date:  2013-03       Impact factor: 18.112

Review 8.  Research review: Cholinergic mechanisms, early brain development, and risk for schizophrenia.

Authors:  Randal G Ross; Karen E Stevens; William R Proctor; Sherry Leonard; Michael A Kisley; Sharon K Hunter; Robert Freedman; Catherine E Adams
Journal:  J Child Psychol Psychiatry       Date:  2009-11-18       Impact factor: 8.982

9.  Male fetus susceptibility to maternal inflammation: C-reactive protein and brain development.

Authors:  Sharon K Hunter; M Camille Hoffman; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman; Amanda J Law
Journal:  Psychol Med       Date:  2019-12-02       Impact factor: 7.723

10.  Prenatal Nicotine Exposure Disrupts Infant Neural Markers of Orienting.

Authors:  Erin King; Alana Campbell; Aysenil Belger; Karen Grewen
Journal:  Nicotine Tob Res       Date:  2018-06-07       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.